Skip to content

Effect of Polypodium in treatment of Coronavirus disease

Evaluation of the effectiveness of a Polypodium root preparation on the management of Covid-19 mild to moderate symptoms a clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120506009651N4
Enrollment
40
Registered
2022-06-07
Start date
2022-05-28
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection. Covid-19, confirmed cases, positive test result

Interventions

Intervention 1: Intervention group: Polypodium root decoction (4 grams of herbal powder in 250 ml of boiling water), received twice a day for a week and followed up one week after treatment. In terms

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: cases who diagnosed as COVID-19 infection by clinical features; laboratory findings (positive C Reactive Protein, Chest X-ray findings, CT scan findings) clinical/lab confirmation of the disease hospitalization due to COVID-19 Stated willingness to participate in the study and sign a written informed consent document

Exclusion criteria

Exclusion criteria: Significant allergic reactions to the herbal drug History of CHF, liver and kidney disorders Patients with diabetes or other endocrine disorders People who are constantly monitored and treated with psychiatric drugs Pregnant/ breast feeding women

Design outcomes

Primary

MeasureTime frame
Clinical/lab confirmation of the disease. Timepoint: Weekly after intervention. Method of measurement: Examination- PCR test.;Hospitalization due to Covid-19. Timepoint: Weekly after intervention. Method of measurement: Hospital report.

Secondary

MeasureTime frame
Improvement of COVID-19 symptoms at end of treatment. Timepoint: End of Treatment (7 days after staring intervention). Method of measurement: General condition of the patient (clinical symptoms).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Mehdi Zarshenas

Shiraz University of Medical Sciences

zarm@sums.ac.ir+98 71 3242 4128

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026